Opportunity Information: Apply for PAR 20 153
The NIH Science Education Partnership Award (SEPA) is a National Institutes of Health (NIH) Research Education Program grant mechanism (R25) designed to support science education and research education activities that align with NIH mission areas. The central purpose of this opportunity is workforce-focused: it funds educational efforts that complement and strengthen the training pipeline needed to meet the United States' biomedical, behavioral, and clinical research needs. This particular funding announcement is explicitly labeled "Clinical Trial Not Allowed," meaning applicants cannot propose projects that include clinical trials as defined by NIH policy; the work must stay on the education and research education side rather than testing clinical interventions in humans.
In practice, SEPA supports projects that improve science literacy, broaden participation in biomedical research, and build stronger pathways into research careers by creating or enhancing educational programs. While the specific program priorities and allowable activities are detailed in the full Funding Opportunity Announcement (FOA), the framing emphasizes initiatives that expand educational access and quality, often through partnerships among schools, higher education institutions, community organizations, and research-intensive environments. NIH also points applicants to examples of active and past SEPA projects as a way to understand typical project models and expectations; these can be reviewed through NIGMS and the broader SEPA community sites (https://www.nigms.nih.gov/Research/crcb/sepa/Pages/default.aspx and http://nihsepa.org).
A notable feature of this opportunity is the strong encouragement for applicants to communicate early with the SEPA Scientific/Research Contact. That pre-submission conversation is meant to help an organization assess whether its concept fits SEPA program objectives and, importantly, the priorities of the National Institute of General Medical Sciences (NIGMS), which is the NIH institute commonly associated with SEPA. This kind of consultation can help applicants avoid misalignment (for example, proposing activities outside the education scope or including elements NIH would consider a clinical trial).
Eligibility is broad and spans many types of U.S.-based organizations and government entities. Eligible applicants listed for this opportunity include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (both with and without 501(c)(3) status, as long as they are not institutions of higher education in those categories); for-profit organizations other than small businesses; small businesses; and other entities as permitted under the FOA. The opportunity also highlights categories of organizations that are specifically welcome as "other eligible applicants," including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations. It also includes certain tribal and regional entities and U.S. territories or possessions, reflecting an emphasis on reaching diverse communities and strengthening education pathways across different regions and populations.
At the same time, there are clear restrictions related to foreign participation. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In other words, applicants must be U.S.-based and must structure the project so that it does not rely on foreign components as part of the proposed work.
From an administrative standpoint, the opportunity is a discretionary grant under the health funding activity category, with CFDA number 93.859, and it is offered by the National Institutes of Health. The funding opportunity number is PAR-20-153, and the record shows a creation date of March 30, 2020. The listed award ceiling is $250,000 (as presented in the source data). The source data also includes an original closing date of July 13, 2022, which indicates that applicants should verify the current status, deadlines, and any reissued or updated versions of the FOA on NIH or Grants.gov, since NIH opportunities are often renewed, amended, or replaced over time.
Overall, SEPA (R25) is best understood as NIH support for education-centered projects that strengthen the pipeline into biomedical and related research fields, frequently through partnerships and scalable educational programming, with a strong emphasis on alignment with NIGMS/SEPA priorities, broad organizational eligibility within the U.S., and strict prohibitions on clinical trials and foreign components.Apply for PAR 20 153
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
- This funding opportunity was created on 2020-03-30.
- Applicants must submit their applications by 2022-07-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
NIH SEPA (R25) Grant (PAR-20-153) FAQs
What is the NIH Science Education Partnership Award (SEPA)?
The NIH Science Education Partnership Award (SEPA) is a National Institutes of Health (NIH) Research Education Program grant mechanism (R25) that supports science education and research education activities aligned with NIH mission areas. The main focus is workforce-oriented: strengthening education and training pathways that help meet U.S. biomedical, behavioral, and clinical research needs.
What is the central purpose of this funding opportunity?
The central purpose is to fund education-centered efforts that complement and strengthen the training pipeline into biomedical and related research fields. In practice, SEPA supports initiatives that improve science literacy, broaden participation in biomedical research, and build stronger pathways into research careers by creating or enhancing educational programs.
Are clinical trials allowed under this SEPA funding announcement?
No. This opportunity is explicitly labeled "Clinical Trial Not Allowed." Applicants cannot propose projects that include clinical trials as defined by NIH policy. The proposed work must remain on the education and research education side rather than testing clinical interventions in humans.
What kinds of projects does SEPA typically support?
Based on the description provided, SEPA supports projects that improve science literacy, broaden participation in biomedical research, and strengthen pathways into research careers through education and research education activities. The opportunity framing emphasizes expanding educational access and quality, often through partnerships among schools, higher education institutions, community organizations, and research-intensive environments. Specific allowable activities and priorities are detailed in the full Funding Opportunity Announcement (FOA).
Does SEPA encourage partnerships or collaborations?
Yes. The opportunity description emphasizes initiatives that often involve partnerships among schools, higher education institutions, community organizations, and research-intensive environments to expand educational access and quality.
Where can applicants see examples of prior or active SEPA projects?
NIH points applicants to examples of active and past SEPA projects. The provided references include the NIGMS SEPA page (https://www.nigms.nih.gov/Research/crcb/sepa/Pages/default.aspx) and the broader SEPA community site (http://nihsepa.org).
Is it recommended to contact NIH before submitting an application?
Yes. Applicants are strongly encouraged to communicate early with the SEPA Scientific/Research Contact. This pre-submission discussion is intended to help determine whether a concept fits SEPA program objectives and the priorities of the National Institute of General Medical Sciences (NIGMS), and to avoid misalignment such as proposing activities outside the education scope or including elements NIH would consider a clinical trial.
Which NIH institute is commonly associated with SEPA?
The description notes that the National Institute of General Medical Sciences (NIGMS) is the NIH institute commonly associated with SEPA, and that alignment with NIGMS/SEPA priorities is important.
Who is eligible to apply for this SEPA opportunity?
Eligibility is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants listed include:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Nonprofit organizations (with or without 501(c)(3) status, as long as they are not institutions of higher education in those categories)
- For-profit organizations other than small businesses
- Small businesses
- Other entities as permitted under the FOA
Are certain institution types specifically welcomed as "other eligible applicants"?
Yes. The opportunity highlights that the following categories are specifically welcome as "other eligible applicants":
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Faith-based or community-based organizations
The description also notes inclusion of certain tribal and regional entities and U.S. territories or possessions, reflecting an emphasis on reaching diverse communities across regions and populations.
Can foreign organizations apply for this grant?
No. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply for this opportunity.
Are foreign components allowed if a U.S. organization applies?
No. The description states that non-domestic components of U.S. organizations are not eligible and that foreign components (as defined by the NIH Grants Policy Statement) are not allowed. Applicants must be U.S.-based and structure the project so it does not rely on foreign components.
What is the funding mechanism and program type?
This is an NIH Research Education Program grant mechanism (R25) under SEPA.
What is the funding opportunity number?
The funding opportunity number provided is PAR-20-153.
What agency offers this grant?
The opportunity is offered by the National Institutes of Health (NIH).
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.859.
What is the listed award ceiling?
The source data lists an award ceiling of $250,000.
When was this opportunity created?
The record shows a creation date of March 30, 2020.
What is the closing date and should applicants verify it?
The source data includes an original closing date of July 13, 2022. Because NIH opportunities are often renewed, amended, or replaced over time, applicants should verify the current status, deadlines, and any reissued or updated versions of the FOA on NIH or Grants.gov.
What should applicants do to ensure their proposal aligns with SEPA requirements?
Based on the description provided, applicants should (1) keep the project education- and research education-focused, (2) avoid proposing any clinical trials, (3) avoid any foreign components, (4) ensure the concept aligns with SEPA and NIGMS priorities, and (5) communicate early with the SEPA Scientific/Research Contact to assess fit before submission.
Browse more opportunities from the same category: Health
Next opportunity: Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
Previous opportunity: Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 20 153
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 20 153) also looked into and applied for these:
| Funding Opportunity |
|---|
| Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) Apply for PAR 20 156 Funding Number: PAR 20 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) Apply for PAR 20 157 Funding Number: PAR 20 157 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for PAR 20 158 Funding Number: PAR 20 158 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) Apply for PAR 20 159 Funding Number: PAR 20 159 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Furthering Health System Reforms in Ukraine Apply for RFI 121 20 000001 Funding Number: RFI 121 20 000001 Agency: Ukraine USAID-Kiev Category: Health Funding Amount: Case Dependent |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Clinical Trial Optional) Apply for RFA AA 20 008 Funding Number: RFA AA 20 008 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 20 525 Funding Number: RFA MH 20 525 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Apply for PA 20 070 Funding Number: PA 20 070 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) Apply for RFA HS 20 003 Funding Number: RFA HS 20 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) Apply for RFA AI 20 029 Funding Number: RFA AI 20 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required) Apply for RFA HL 22 006 Funding Number: RFA HL 22 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 20 019 Funding Number: RFA RM 20 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Noninvasive mTBI Tool RFI Apply for HU000120R0047 Funding Number: HU000120R0047 Agency: Uniformed Services Univ. of the Health Sciences Category: Health Funding Amount: Case Dependent |
| IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional) Apply for PAR 20 175 Funding Number: PAR 20 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). Apply for RFA AI 20 027 Funding Number: RFA AI 20 027 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Apply for PA 20 072 Funding Number: PA 20 072 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Apply for PAR 20 178 Funding Number: PAR 20 178 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Apply for PAR 20 177 Funding Number: PAR 20 177 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) Disease Modifying Therapies for Chronic Lung Diseases (U24 Clinical Trial Required - Infrastructure) Apply for RFA HL 21 012 Funding Number: RFA HL 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required) Apply for RFA HL 21 013 Funding Number: RFA HL 21 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 153", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
